October 04, 2022
A $900 million settlement of doctor-bribing allegations against Biogen shattered False Claims Act records and gave a boutique Boston firm its second history-making lawsuit under the FCA. The lead counsel for whistleblowers in each case spoke with Law360 about how the resolution could change the pharmaceutical industry's kickback culture, how his earlier suit improved drugmaker conduct, and how he built two of the FCA's seminal cases.
September 27, 2022
A former pharmaceutical manager's $250 million cut of Biogen's $900 million payments-for-prescriptions settlement is among the largest whistleblower awards in U.S. history, delivering a shot of adrenaline to other False Claims Act cases not backed by the U.S. Department of Justice's muscle, attorneys said Tuesday.
September 26, 2022
A Massachusetts federal judge gave the final green light Monday to a deal that will see Biogen Inc. pay $900 million to settle decade-old claims with the federal government, as well as several states, that the company paid illegal kickbacks to doctors and other health care professionals.
July 20, 2022
Biogen Inc. has agreed to pay $900 million to settle claims that the company paid illegal kickbacks to doctors and other health care professionals just days before the decade-old case was about to go to trial.